Inventor

Ze'ev Shaked

Inventor

Berkeley, CA, US

Overview

1985–2016

Patent span

Human necessities

Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes34%

C07KPeptides34%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%

C12NMicroorganisms or enzymes7%

G01NInvestigating or analysing materials by determining their chemical or physical properties7%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%

PatentTitleYear

9,498,528'Treatment of multiple sclerosis (MS)'2016 8,540,999'Allergenic proteins and peptides from Japanese cedar pollen'2013 7,482,008'Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor'2009 7,288,256'T cell epitopes of the major allergens from dermatophagoides (house dust mite)'2007 6,982,326'Allergenic proteins and peptides from Japanese cedar pollen'2006 6,602,910'D-enantiomer of DFMO and methods of use therefor'2003 6,277,411'Pharmaceutical formulation containing DFMO for the treatment of cancer'2001 6,268,491'T cell epitopes of the major allergens from dermatophagoides (house dust mite)'2001 6,090,386'T cell peptides of the CRX JII allergen'2000 5,968,526'T cell epitopes of the major allergens from Dermatophagoides (house dust mite)'1999 5,820,862'T cell epitopes of the major allergens from dermatophagoides (house dust mite)'1998 5,578,310'Topical bioadhesive ointment compositions and their use in wound healing'1996 5,183,746'Formulation processes for pharmaceutical compositions of recombinant .beta. -'1993 5,037,644'Pharmaceutical compositions of recombinant interleukin-2 and formulation processes'1991 4,961,969'Process for recovering microbially produced interferon-.beta.'1990 4,894,330'Purification of recombinant beta-interferon incorporating RP-HPLC'1990 4,752,585'Oxidation-resistant muteins'1988 4,530,787'Controlled oxidation of microbially produced cysteine-containing proteins'1985

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1985–1991Patents assigned to CETUS CORP (5)· patent assignee history

1985–2013Based in Berkeley, CA, US· patent location history

1998–2006Patents assigned to IMMULOGIC PHARMA CORP (3)· patent assignee history

2001–2003Patents assigned to ILEX ONCOLOGY INC (2)· patent assignee history

2001Based in Boston, MA, US· patent location history

2003–2016Based in San Antonio, TX, US· patent location history

2007–2013Patents assigned to MERCK PATENT GMBH (3)· patent assignee history

2016Patents assigned to ALCAFLEU MAN GMBH & CO KG (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CETUS CORP	5	1985–1991
IMMULOGIC PHARMA CORP	3	1998–2006
MERCK PATENT GMBH	3	2007–2013
ILEX ONCOLOGY INC	2	2001–2003
ALCAFLEU MAN GMBH & CO KG	1	2016

Locations

Location	Patents	Span
Berkeley, California, US	15	1985–2013
San Antonio, Texas, US	2	2003–2016
Boston, Massachusetts, US	1	2001